Literature DB >> 7793861

Mechanism of tonB-dependent transport of KP-736, a 1,5-dihydroxy-4-pyridone-substituted cephalosporin, into Escherichia coli K-12 cells.

Y Tatsumi1, T Maejima, S Mitsuhashi.   

Abstract

The mechanism of transport of KP-736, a novel cephalosporin with a 1,5-dihydroxy-4-pyridone moiety at the C-7 position, into the Escherichia coli K-12 cell was investigated by determining the susceptibilities of iron transport mutants to KP-736. The tonB mutant showed a higher degree of resistance to KP-736, indicating that KP-736 was incorporated into E. coli cells via the tonB-dependent iron transport system. The product of the exbB gene was also necessary for the maximal antibacterial potency of KP-736. Cir-lacking and Fiu-lacking mutants showed a moderate level of resistance to KP-736. However, mutants lacking any one of the proteins FepA, FecA, FhuA, and FhuE did not show any increased resistance to KP-736. Two types of spontaneous mutants (e.g., KT1004 and KT1011) could be isolated from cir and fiu mutants by selection for KP-736 resistance and showed the same level of resistance to KP-736 as a tonB mutant. KT1004 showed tonB phenotypes, resistance to phage phi 80, and loss of FecA, whereas KT1011 did not. KT1011 lost the ability to express both Cir and Fiu proteins. These results indicate that the Cir and Fiu outer membrane proteins are involved specifically in the tonB-dependent transport process of KP-736. Against OmpF- and OmpC-deficient transformants producing various groups of beta-lactamases, KP-736 was more effective than the other cephalosporins tested.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793861      PMCID: PMC162593          DOI: 10.1128/AAC.39.3.613

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  In vitro antibacterial activity of KP-736, a new cephem antibiotic.

Authors:  T Maejima; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

2.  E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system.

Authors:  N A Watanabe; T Nagasu; K Katsu; K Kitoh
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

3.  Domains involved in osmoregulation of the ompF gene in Escherichia coli.

Authors:  K Inokuchi; M Itoh; S Mizushima
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

4.  Mode of action of BO-1341: transport pathway through the outer membrane of Escherichia coli.

Authors:  M Sanada; T Hashizume; K Matsuda; S Nakagawa; N Tanaka
Journal:  Drugs Exp Clin Res       Date:  1988

5.  Biological activity of BO-1236, a new antipseudomonal cephalosporin.

Authors:  S Nakagawa; M Sanada; K Matsuda; N Hazumi; N Tanaka
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

6.  Cloning of the repressor protein gene of iron-regulated systems in Escherichia coli K12.

Authors:  K Hantke
Journal:  Mol Gen Genet       Date:  1984

7.  Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae.

Authors:  K Bush; S K Tanaka; D P Bonner; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

8.  Semisynthetic beta-lactam antibiotics. IV. Synthesis and antibacterial activity of new ureidocephalosporin and ureidocephamycin derivatives containing a catechol moiety or its acetate.

Authors:  N Ohi; B Aoki; T Shinozaki; K Moro; T Kuroki; T Noto; T Nehashi; M Matsumoto; H Okazaki; I Matsunaga
Journal:  Chem Pharm Bull (Tokyo)       Date:  1987-05       Impact factor: 1.645

9.  In-vitro antibacterial activity of L-105, a new cephalosporin.

Authors:  M Hikida; M Inoue; S Mitsuhashi
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

10.  In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.

Authors:  K Katsu; K Kitoh; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

View more
  8 in total

Review 1.  Colicins--exocellular lethal proteins of Escherichia coli.

Authors:  J Smarda; D Smajs
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

2.  Defining Baseline Mechanisms of Cefiderocol Resistance in the Enterobacterales.

Authors:  Patricia J Simner; Stephan Beisken; Yehudit Bergman; Michael Ante; Andreas E Posch; Pranita D Tamma
Journal:  Microb Drug Resist       Date:  2021-10-06       Impact factor: 3.431

3.  Involvement of Fe uptake systems and AmpC β-lactamase in susceptibility to the siderophore monosulfactam BAL30072 in Pseudomonas aeruginosa.

Authors:  Christian van Delden; Malcolm G P Page; Thilo Köhler
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

4.  In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains.

Authors:  Naoki Kohira; Joshua West; Akinobu Ito; Tsukasa Ito-Horiyama; Rio Nakamura; Takafumi Sato; Stephen Rittenhouse; Masakatsu Tsuji; Yoshinori Yamano
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

5.  Role of receptor proteins for enterobactin and 2,3-dihydroxybenzoylserine in virulence of Salmonella enterica.

Authors:  W Rabsch; U Methner; W Voigt; H Tschäpe; R Reissbrodt; P H Williams
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Structure of colicin I receptor bound to the R-domain of colicin Ia: implications for protein import.

Authors:  Susan K Buchanan; Petra Lukacik; Sylvestre Grizot; Rodolfo Ghirlando; Maruf M U Ali; Travis J Barnard; Karen S Jakes; Paul K Kienker; Lothar Esser
Journal:  EMBO J       Date:  2007-04-26       Impact factor: 11.598

Review 7.  New Perspectives on Antimicrobial Agents: Cefiderocol.

Authors:  Erin K McCreary; Emily L Heil; Pranita D Tamma
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

8.  In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study).

Authors:  Meredith A Hackel; Masakatsu Tsuji; Yoshinori Yamano; Roger Echols; James A Karlowsky; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.